Alzheimer's disease

Homer L. Hartage Releases Vital Guidebook on Navigating Guardianship Challenges Amid Rising National Concern

Retrieved on: 
Thursday, March 21, 2024
ThriftBooks, Respect, Knowledge, Hope, Family, Barnes & Noble, Nature, Walmart, Amazon (company), Alzheimer's disease, Disability studies, Dementia, Competition, Guide

ORLANDO, Fla., March 21, 2024 /PRNewswire/ -- Expert care giver and advocate, Homer L. Hartage, recently announced the upcoming May release of his new guidebook to help lead Floridians and others through the complex world of legal guardianship. "Family and Professional Guardianship" addresses how to achieve the critical balance between safeguarding vulnerable individuals while also managing their legacies, preserving their dignity, and securing their autonomy.

Key Points: 
  • "Family and Professional Guardianship: A Compete Planning Guidebook for Guardians of Adults and Children with Dementia, Alzheimer's and Developmental Disabilities."
  • ORLANDO, Fla., March 21, 2024 /PRNewswire/ -- Expert care giver and advocate, Homer L. Hartage , recently announced the upcoming May release of his new guidebook to help lead Floridians and others through the complex world of legal guardianship.
  • "There is a way to do that with care and respect, and I wanted to shed some light on how.
  • I will explain the different types of guardianship, including person, property, limited, voluntary, guardian advocate, veteran, plenary, family, and professional guardianship.

Lost Money on Anavex Life Sciences Corporation(AVXL)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky

Retrieved on: 
Wednesday, March 20, 2024
Alzheimer's disease, Telephone, Patient, News, LLP, CLASS, Rett syndrome, Clinical trial, MCI, Radar, NEXT, COST, Court, Cryptocurrency

NEW YORK, March 20, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Anavex Life Sciences Corporation ("Anavex Life Sciences" or the "Company") (NASDAQ: AVXL) of a class action securities lawsuit.

Key Points: 
  • NEW YORK, March 20, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Anavex Life Sciences Corporation ("Anavex Life Sciences" or the "Company") (NASDAQ: AVXL) of a class action securities lawsuit.
  • CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Anavex Life Sciences investors who were adversely affected by alleged securities fraud between February 1, 2022 and January 1, 2024.
  • Follow the link below to get more information and be contacted by a member of our team:
    AVXL investors may also contact Joseph E. Levi, Esq.
  • For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.

Midlife Women's Health Leader Midi Health Partners with Neurotrack to Give Women a Quick and Easy Tool to Help Discern Menopause Brain Fog from More Serious Cognitive Impairment

Retrieved on: 
Tuesday, March 19, 2024
Smartphone, Deficit spending, Partnership, Patient, Menopause, News, Woman, Alzheimer's disease, LOS, Hot, Dementia, Medical imaging

LOS ALTOS, Calif., March 19, 2024 /PRNewswire/ -- Midi Health, the leading virtual care clinic focused exclusively on women navigating midlife hormonal transition, and Neurotrack, maker of innovative digital cognitive assessments, today announced a first-of-its-kind partnership that will help the nearly three-fourths of women who experience midlife brain fog determine whether their symptoms are linked to menopause or indicative of more severe cognitive impairment.

Key Points: 
  • For the vast majority of women, the brain fog experienced during the menopause transition is temporary and resolves over time, but it's important to investigate all cognitive complaints.
  • To tackle this challenge, Midi teamed up with Neurotrack, the leading company developing digital cognitive assessments for more than a decade.
  • In most cases, Midi can help patients manage and alleviate the impact of brain fog and other troublesome symptoms of perimenopause.
  • "Brain fog in menopause is super common — 74 percent of Midi patients report this symptom, as prevalent as hot flashes.

PET PARTNERS LOOKING FOR SOME SPECIAL ANIMALS

Retrieved on: 
Tuesday, March 19, 2024
Rabbit, Intellectual, Temperament, Rat, Veteran, Partnership, Library, Patient, School, Hospital, Cat, News, Bird, Student, Dog, Alzheimer's disease, Pet, Animal, PTSD

BELLEVUE, Wash., March 19, 2024 /PRNewswire/ -- It's no secret animals can have a positive impact on a person's mental and physical health. That's why every year thousands of facilities such as libraries, schools, hospitals, assisted living, and more ask Pet Partners volunteers to bring therapy animals to visit and provide comfort to their students, residents, patients, and customers. This April 30 is a special day to recognize the beneficial role therapy dogs and other therapy animals, in partnership with their human companions, play in creating happier, healthier communities.

Key Points: 
  • That's why every year thousands of facilities such as libraries, schools, hospitals, assisted living, and more ask Pet Partners volunteers to bring therapy animals to visit and provide comfort to their students, residents, patients, and customers.
  • Pet Partners is calling for people to volunteer with their pets as therapy animal teams to help support people in need.
  • Pet Partners is the nation's leading registry of therapy animals, and their volunteer teams can't fulfill all the requests they receive for therapy animal visits.
  • "An animal's temperament is what determines whether they might make a good registered therapy animal with Pet Partners, not any specific species or breed," said Pet Partners President and CEO C. Annie Peters.

The University of Texas Health Science Center at San Antonio announces the passing of William L. Henrich, MD, president since 2009

Retrieved on: 
Friday, March 15, 2024
Alzheimer's disease, Barshop Institute, Biomedical Research, Health, Patient, History, Quality of life, Humour, University, MACP, Love, NIA, Pandemic, Dementia, Ageing, NCI, Obesity, Innovation, UT System, Diabetes, SAN, NIH, Workforce, Transplant, Intelligence, Public, FACP, Integration, News, Textbook, Cancer, Dialysis, Haematopoietic system, Family, Neurodegenerative disease, Dentistry, Growth, COVID-19, School, Life, University of Texas System, MARC, Nursing

SAN ANTONIO, Texas, March 14, 2024 /PRNewswire-PRWeb/ -- It is with profound sadness that The University of Texas of Health Science Center at San Antonio (UT Health San Antonio) announces that William L. Henrich, MD, MACP, president of UT Health San Antonio, passed away this morning, March 14, 2024. There will be announcements about Dr. Henrich's memorial services soon.

Key Points: 
  • SAN ANTONIO, Texas, March 14, 2024 /PRNewswire-PRWeb/ -- It is with profound sadness that The University of Texas of Health Science Center at San Antonio (UT Health San Antonio) announces that William L. Henrich, MD, MACP, president of UT Health San Antonio, passed away this morning, March 14, 2024.
  • Dr. Henrich was able to return as president in February 2013 and presided over the unprecedented growth experienced by UT Health San Antonio.
  • The University of Texas Health Science Center at San Antonio (UT Health San Antonio), a primary driver of San Antonio's $44.1 billion health care and biosciences sector, is the largest academic research institution in South Texas with an annual research portfolio of $413 million.
  • Monica Taylor, The University of Texas Health Science Center at San Antonio, 210-450-8970, [email protected] , https://news.uthscsa.edu/

Watercrest Executive Chef Manny Florez of Market Street Viera Wins Best Chef at the One Senior Place 'A Taste of Senior Living' Competition

Retrieved on: 
Thursday, March 14, 2024
Cooking, Senior living, Senior, Taste, News, Alzheimer's disease, Cheese, Retirement, Dementia, Baking

VERO BEACH, Fla., March 14, 2024 /PRNewswire/ -- Watercrest Senior Living celebrates their award-winning Chef Manny Florez of Market Street Memory Care Residence Viera who was crowned Best Chef at the One Senior Place "A Taste of Senior Living" cooking competition this month.

Key Points: 
  • VERO BEACH, Fla., March 14, 2024 /PRNewswire/ -- Watercrest Senior Living celebrates their award-winning Chef Manny Florez of Market Street Memory Care Residence Viera who was crowned Best Chef at the One Senior Place "A Taste of Senior Living" cooking competition this month.
  • Executive Chef Manny delighted the crowd with his modern twist on a traditional favorite: the grilled cheese sandwich.
  • With savory brie cheese, sweet fig spread and toasted sourdough, Chef Manny won the popular vote for Best Appetizer.
  • The highly popular annual event, " A Taste of Senior Living ," is designed to showcase the extraordinary amenities found in local senior communities.

Edward Jones' Annual Purpose, Inclusion and Citizenship Report Highlights Commitment to Client, Colleague and Community Impact

Retrieved on: 
Wednesday, March 13, 2024
NABA, Hispanic, Health, Alzheimer's disease, Learning, Communication, Partnership, Education, Life, Student, Organic, Woman, CO2, Edward Jones, GDP, NBMBAA, Retirement, Workforce, BRG, Interfaith dialogue, National Association, Tree, Arbor, Financial adviser

ST. LOUIS, March 13, 2024 /PRNewswire/ -- Financial services firm Edward Jones released its sixth-annual Purpose, Inclusion and Citizenship Report, "Growing Our Impact," featuring the many ways Edward Jones advanced its business and community goals throughout 2023.

Key Points: 
  • ST. LOUIS, March 13, 2024 /PRNewswire/ -- Financial services firm Edward Jones released its sixth-annual Purpose, Inclusion and Citizenship Report, "Growing Our Impact," featuring the many ways Edward Jones advanced its business and community goals throughout 2023.
  • The report describes the achievements of Edward Jones' approximately 54,000 associates throughout North America through year-end 2023.
  • The report also includes Edward Jones' economic impact throughout 2023.
  • For every job Edward Jones directly creates as an employer, another 1.8 jobs are created in the community.

High School Seniors Win $1.8 Million at Regeneron Science Talent Search 2024 for Innovative Scientific Research on Artificial Intelligence, Cancer Metabolism and Mathematical Optimization

Retrieved on: 
Wednesday, March 13, 2024
Lung cancer, Pollination, Bee, Metabolism, Culture, Gene, Algorithm, Alzheimer's disease, National Medal, Growth, Aditi, Gene expression, Survival, Cell, Bone marrow, Trustee, School, Brain, Research, Science News, RET, Highlands Ranch, Colorado, Death, Macrophage, ARD International Music Competition, Society, Thought, Student, Nobel Prize, STEM, CO, Cancer, MYC, ChatGPT, Machine learning, Society for Science, Liver, STS, Pharmaceutical industry

TARRYTOWN, N.Y. and WASHINGTON, March 12, 2024 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Society for Science (the Society) announced that Achyuta Rajaram, 17, of Exeter, NH, won the top award in the Regeneron Science Talent Search (STS) 2024, America's oldest and most prestigious science and math competition for high school seniors.

Key Points: 
  • This knowledge sheds light on what these algorithms are "thinking," which can help make them more effective, fair and safe.
  • "Congratulations to the winners of this year's Regeneron Science Talent Search," said Maya Ajmera, President and CEO, Society for Science and Executive Publisher, Science News.
  • The Regeneron Science Talent Search empowers young people who are passionate about innovation and using scientific discovery to contribute to improving our world.
  • In total, Regeneron awarded $3.1 million in prizes through the Regeneron Science Talent Search 2024, including $2,000 to each of the top 300 scholars and their schools.

Most New Yorkers Caring for Aging Loved Ones Don't Believe State Government Provides Enough Support

Retrieved on: 
Tuesday, March 12, 2024
Alzheimer's disease, AARP, Caregiver, Housekeeping, Nursing, Legislature, Transport, Ageing, Woman, Long-term care, Nursing care plan, Government, State, Dementia, Residential care

Nearly four in ten family caregivers who responded to the survey for the report – titled "Voters Age 40 and Older in New York State: Their Attitudes and Opinions About Caregiving and Long-Term Care" -- say they care for or have cared for a relative, with the majority of caregivers (66%) being women. One in three caregivers say they care or cared for someone with a decline in mental functioning, such as Alzheimer or dementia.

Key Points: 
  • One in three caregivers say they care or cared for someone with a decline in mental functioning, such as Alzheimer or dementia.
  • "Our survey shines a spotlight on an issue that many New Yorkers are living every day as family caregivers," said AARP New York State Director Beth Finkel.
  • "Across New York State, family caregivers are juggling jobs while raising their children and providing essential help to an aging loved one.
  • Nearly 70% of caregivers say they cared for their loved ones while also being employed either full- or part-time.

Metabolon and Cardiff University Centre for Neuropsychiatric Genetics and Genomics Forge Alliance to Propel Multiple Sclerosis Research

Retrieved on: 
Tuesday, March 12, 2024
Plasma, Metabolomics, Disease, Multiple sclerosis, CSF, Partnership, Central nervous system, Biomedical Research, Patient, Biomarker, Research, Parkinson's disease, Cerebrospinal fluid, Medicine, Cardiff University, Alzheimer's disease, Pathology, Pharmaceutical industry

MORRISVILLE, N.C., March 12, 2024 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, today announced a partnership with Cardiff University Centre for Neuropsychiatric Genetics and Genomics, a renowned institution at the forefront of biomedical research. This collaboration is poised to discover new biomarkers to accelerate advancements in the understanding and treatment of multiple sclerosis (MS).

Key Points: 
  • This collaboration is poised to discover new biomarkers to accelerate advancements in the understanding and treatment of multiple sclerosis (MS).
  • MS is a neuroinflammatory disorder that affects the central nervous system, giving rise to a range of physical and neuropsychological challenges.
  • For years, the Cardiff University Centre for Neuropsychiatric Genetics and Genomics has been following MS patients and developing cutting-edge tools for clinicians and researchers.
  • To learn more about Metabolon's research and development efforts in neurodegeneration diseases, including Alzheimer's, Parkinson's, and MS, visit https://www.metabolon.com/applications/neuroscience/